Download video

MD to Pharma : Getting into Pharma as a Doctor. Alternative careers

157K views

Disruptive Doctors®

5 years ago

MD to Pharma : Getting into Pharma as a Doctor. Alternative careers

MD to Pharma : Getting into Pharma as a Doctor. Alternative careers

Approaching Integrated Care in T2D and its Related Conditions
0:31
Approaching Integrated Care in T2D and its Related Conditions
by BoehringerUS
Driver mutations predicting clinical outcomes upon MRD-guided venetoclax plus ibrutinib in R\/R CLL
1:51
Driver mutations predicting clinical outcomes upon MRD-guided venetoclax plus ibrutinib in R\/R CLL
by VJHemOnc – Video Journal of Hematology \& HemOnc
GM2 Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD)
5:48:31
GM2 Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD)
by NTSAD
UW Medicine Pre-Transplant Pharmacist Education Part 2
11:13
UW Medicine Pre-Transplant Pharmacist Education Part 2
by UW Medicine
MCQ Discussion daily I MCQ 2
3:24
MCQ Discussion daily I MCQ 2
by Dr Bharath Kumar V D
The potential of MDM2 inhibitors in MPNs: past and ongoing studies of navtemadlin
9:54
The potential of MDM2 inhibitors in MPNs: past and ongoing studies of navtemadlin
by VJHemOnc – Video Journal of Hematology \& HemOnc
MCQS on Definition of manufestation of MD
10:47
MCQS on Definition of manufestation of MD
by DOT RAISE FOUNDATION
Amphray Laboratories
1:15
Amphray Laboratories
by Hoang Truong 02
How Vitamin K Could Play a Role in Brain Health
11:10
How Vitamin K Could Play a Role in Brain Health
by Dr. William Wallace
T2D Diabetes Supplies and Packing Tips
7:45
T2D Diabetes Supplies and Packing Tips
by Kim Not Kimberly
Mezigdomide Combined with Dex in Relapsed\/Refractory MM Pts: CC-92480-MM-001 Trial
10:45
Mezigdomide Combined with Dex in Relapsed\/Refractory MM Pts: CC-92480-MM-001 Trial
by International Myeloma Foundation
Simplify Dry Eye Management with I-MED Pharma’s Innovative B2B2C Program
0:39
Simplify Dry Eye Management with I-MED Pharma’s Innovative B2B2C Program
by I-MED Pharma
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
58:39
Targeting Cancer at the Molecular Level: Repurposed Drugs and Integrative Strategies
by Fit Rx Health + Wellness
Phase II trial of daratumumab, bortezomib, lenalidomide and dexamethasone in HR-SMM
1:45
Phase II trial of daratumumab, bortezomib, lenalidomide and dexamethasone in HR-SMM
by VJHemOnc – Video Journal of Hematology \& HemOnc
FCP2 \/ MRCP2 Board Review : Haematology 1
10:34
FCP2 \/ MRCP2 Board Review : Haematology 1
by Internal medicine Algorithms and Mnemonics
Drugs for Neurodegenerative Disease Part 2 (Pharmacology #30)
21:43
Drugs for Neurodegenerative Disease Part 2 (Pharmacology #30)
by Medi Medix
Delivering Innovation in Dry Eye Management: I-MED Pharma's B2B2C Program
1:04
Delivering Innovation in Dry Eye Management: I-MED Pharma's B2B2C Program
by I-MED Pharma
A Phase II study of daratumumab and pomalidomide in previously treated patients with AL amyloidosis
1:48
A Phase II study of daratumumab and pomalidomide in previously treated patients with AL amyloidosis
by VJHemOnc – Video Journal of Hematology \& HemOnc